This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Nanovation Therapeutics Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Deaglan Arnold: Innovator in Therapeutic Delivery Systems
Introduction
Deaglan Arnold is a notable inventor based in London, Canada. He has made significant contributions to the field of therapeutic delivery systems, particularly through his innovative work on ionizable lipids.
Latest Patents
Arnold holds a patent for "Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents." This invention provides an ionizable, cationic amino lipid or a pharmaceutically acceptable salt thereof. The ionizable, cationic amino lipid is designed to enhance the delivery of nucleic acids and other therapeutic agents, showcasing Arnold's commitment to advancing medical technology.
Career Highlights
Deaglan Arnold is currently associated with Nanovation Therapeutics Inc., where he continues to develop groundbreaking solutions in the field of drug delivery. His work is pivotal in addressing challenges related to the effective delivery of therapeutic agents.
Collaborations
Arnold collaborates with talented individuals such as Nagavenkata Durga Prasad Atmuri and Fariba Saadati, contributing to a dynamic research environment that fosters innovation.
Conclusion
Deaglan Arnold's contributions to the field of therapeutic delivery systems exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in drug delivery technologies.